Tackle Regulation Change & Increased Cost Pressures in your Life Sciences Supply Chain

With healthcare companies focusing primarily on developing and commercializing novel therapies for the welfare of patients, and enjoying healthy profit margins, Supply Chain has not typically been considered a core competence of overall business success.

Despite this background, many healthcare companies have achieved significant innovations in their supply chain operations. In 2009, AMR developed the first Healthcare Top 25 ranking, to recognize the leaders in healthcare supply chain.

In this session:

• Hear the key traits that define a top-25 Healthcare supply chain
• Discover which best practices the winners have in common
• Hear Gartner’s exclusive insight into the strengths and weaknesses of leading Life Sciences companies
• Learn how you can apply their key strategies and put your supply chain among the industry’s best

Todd Applebaum, Life Sciences Lead Analyst, Gartner Group

• As constraints on revenues increase understand how supply chain data systems can improve your management strategies and enable you to do more with less
• Empower supply chain management in your organization to encourage wider collaboration with partners and clinicians and cut costs in the process
• Identify cost/quality trade-offs whilst still ensuring patient safety

In this Life Sciences 'Industry Consortium', discuss how best to collaborate end-to-end - from the manufacturer right through to the patient

• Respond to the critical nature of Life Sciences Supply Chain by integrating common visibility standards across your value chain; from manufacturing to bedside
• Eliminate errors in your supply chain by maximizing the use of technology -  enable effective use of available technology resources by implementing common standards goals

Rick Demarais, WW Supply Chain Director- Johnson & Johnson

Sophia Sharp-Donaldson, Senior Director - Global Supply Chain, Baxter

Tony Benedict, VP Supply Chain Vanguard Systems, Abrazo Healthcare

John Roberts, Director Healthcare, GS1 US

• Learn first-hand how applying lean to transactional processes, customer service, e-commerce and distribution can reduce supply chain inefficiency and waste
• Take a fundamental look at how you operate - combine, consolidate and re-organize your supply chain to discover key areas of waste. Respond to pressure to reduce cost and improve service
• Manage the cultural shift of introducing lean thinking - populate your environment with ‘lean thinkers’ to create a harmonious crossover to lean

• What is the federal government is going to do with UDI? Hear how far into preparation the FDA are with formulating the unique device identification rule
• Understand what you need to do to make your high risk devices compliant with the UDI regulation - learn from GS1 on how they are synchronising their GDSN database to the UDI database to make the transition easier
• Minimize the cost element of adhering to UDI with up to the minute information on the new ERP data systems that are ready to bear the brunt

• Mitigate pharma supply chain risks and ensure that you comply with increasingly strict global regulations such as good practice guides from the FDA, EU Annex 13, ICH, the World Health Organization and others
• Ensure integrated door-to-door management of all key players in your supply chain by providing visibility throughout. Guarantee transfer of accountability between partners at key milestones throughout your relationships
• Adapt to trends towards increased global outsourcing and cooperation between pharmaceutical and biotech firms with the information on the latest and most reliable track & trace systems for temperature sensitive products
•  Avoid improper handling of temperature-sensitive pharmaceuticals by implementing an audit system that can cope with varied regulations between organizations and countries

Patricia Seymour, Fmr. Supply Chain Director, Millennium Pharmaceuticals

John Griffin, Senior Manager Clinical Supply, EnVivo Pharmaceuticals

As markets continue to evolve, Medical Device OEMs under pressure to reduce costs, improve service levels, and increase market penetration are looking to Flextronics for innovative solutions spanning:

Design

Manufacturing

Distribution

Aftermarket Services

An exciting aspect of these engagements is the growing interest in “supply chain design” as OEMs seek to optimise transportation, warehousing, inventory and service performance across their global networks.

This presentation offers an outsource partner perspective that should be of interest to anyone contemplating supply chain change.

Julian Carroll - Director, Account Management - Flextronics Global Services & Software

Split into groups to debate how your company is preparing for e-pedigree.

• Evaluate the latest timelines put forward by California and get expert insight on what you need to do to best prepare for serialization
• Is there a burning platform for one national system of serialization requirements? Plug yourself into the discussion and adapt your operations with lessons-learned from your peers
• What are you preparing for? Aim towards implementing a system that can cope with all eventualities in serialization regulation - is it truly possible to prepare for all possibilities?

Industry Boardroom Session

• Understand the steps that your life sciences competitors take when sourcing LSP partners - how should you evaluate the capabilities of potential partners?
• Debate the role that 3PLs should take in innovating to provide life sciences-specific solutions for their customers. Whose responsibility is it to understand new developments in the industry? Hear how some 3PLs are taking on more information rich responsibility by providing ‘country playbooks’ for their customers
• Tackle logistics restraints in less developed markets, such as a lack of basic infrastructure and adequate systems for handling temperature-sensitive products. Should you rely on local players to guide you through?

• Ensure your brand integrity with insight into key supply chain security advances in life sciences supply chain
• Avoid the costly impact of counterfeit drug circulation in the legitimate US distribution channel by ensuring that you work with the right partners right across your value chain
• Ensure that you implement the right SLAs and select the right partners for your supply chain to protect against loss, piracy and theft - from tracking and tracing to the latest in securing your cargo

Each table will elect a moderator and a note taker (so that you can take those key points away with you). At the end of the session your event moderator will collect all the notes and summarise the key findings to round off the discussions.

• Maintain crucial product integrity and ensure that your life sciences supply chain is responsive to changing market conditions by developing supplier agility strategies
• Discover why leading life sciences supply chain executives are going beyond metrics, data and SLAs, and leveraging personal relationships with partners to add an extra layer of supply chain security that money can’t buy
• Learn which tools and strategies leading life sciences supply chains are using to improve partner relationships across the extended value chain. Ensure that your tools allow you to spot issues before they occur and quickly react to disruptions

Presentation:

Laurent Boer, Vice President - Global Distribution & Logistics, Genzyme

Following on from Laurent Boer's presentation, discuss the methods that you should be using to ensure risk free supplier management.

Presentation:

Laurent Boer, Vice President - Global Distribution & Logistics, Genzyme

David Petricone, Strategic Sourcing Analyst, MIT

• Discover how working with small and diverse suppliers has enabled J&J to support long-term growth objectives and add value to their businesses by providing innovative solutions to manufacturing and R&D efforts
• Let your suppliers grow with you to ensure that you create a wider and more reliable supplier base
• Kill two birds with one stone - how supplier diversity can aid your legislative adherence practices

Discover who has supply chain experience outside of Life Sciences, what they’ve learned about customer segmentation and how you can apply this innovative practice to the healthcare industry.

We’ll discuss how to:

• Enhance your supply chain operations to enable you to offer differentiated responses to varying supply chain demands from customer segments all around the globe
• React to what your customers truly need by understanding the diversity of your customer base - gather the right intelligence and translate true visibility to your global supply chain partners
• Overcome patent expiration, inflexibility, squeezed margins and rigid networks by creating a segmented network that emphasizes agility, cost and service